6C4C.22

ICD-11 MMS 2026-01

MDMA or related drug dependence, including MDA, sustained partial remission

Description

After a diagnosis of MDMA or related drug dependence, including MDA, and often following a treatment episode or other intervention (including self-help intervention), there is a significant reduction in consumption of MDMA or related drugs, including MDA, for more than 12 months, such that even though intermittent or continuing use of MDMA or related drugs, including MDA, has occurred during this period, the definitional requirements for dependence have not been met.

Index terms

  • MDMA or related drug dependence, including MDA, sustained partial remission
  • Ecstasy or related drug dependence, sustained partial remission

Excludes

  • 6C4C.0 – Episode of harmful use of MDMA or related drugs, including MDA
  • 6C4C.1 – Harmful pattern of use of MDMA or related drugs, including MDA

Exclusions from above levels

  • QE11.6 – Hazardous use of MDMA or related drugs
  • QE62 – Uncomplicated bereavement
  • QE84 – Acute stress reaction

Sibling codes

  • 6C4C.20 – MDMA or related drug dependence, including MDA, current use
  • 6C4C.21 – MDMA or related drug dependence, including MDA, early full remission
  • 6C4C.23 – MDMA or related drug dependence, including MDA, sustained full remission
  • 6C4C.2Z – MDMA or related drug dependence, including MDA, unspecified

Foundation entity

MDMA or related drug dependence, including MDA, sustained partial remission – http://id.who.int/icd/entity/213499118

Allowed postcoordination axes

Part of: 6C4C.2: MDMA or related drug dependence, including MDA › 6C4C: Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA] › 06: Mental, behavioural or neurodevelopmental disorders